CMBT

Cmb.Tech N.V.

46
Fundamentals58/ 100
Valuation47/ 100
Upside potential33/ 100
Risk potential42/ 100

CMBT's fundamentals are mixed: revenue more than doubled, but its operating margin fell 8 points to 33%. Its PE of 6.1x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect earnings to fall sharply, though they disagree widely on how much.

CMBT Fundamentals

MetricStatus
Healthy
Strong
Healthy
Under pressure

CMBT's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.

CMBT PE Valuation

CHEAPFAIREXPENSIVE5.9x12x18x23x
CHEAPFAIREXPENSIVE5.9x12x18x23x
LevelPEPriceVs current
Cheap2.9x$8.29-53%
Current6.1x$17.61—
Fair7.7x$22.14+26%
Forward9.8x$17.61—
Expensive18x$50.69+188%

Historical ranges are pointers, not guarantees.

CMBT's PE is in its fair range at 6.1x, but its recent earnings include one-off gains. Analysts expect earnings to fall, which would put today's price at 9.8x next year's earnings.

CMBT Forward outlook

MetricOutlook
Strongly deteriorating
Strong decline
Decline
Strongly weakening
Limited
Low

Analysts expect CMBT's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.

CMBT Risk to reward

ScenarioChangePrice
Upside+21%$21.26
Downside-42%$10.18

Calculated from the latest close: $17.61 on Nov 12.

CMBT's one-year downside scenario is about twice its upside: −42% against +21%.

CMBT Earnings Per Share

Q3 2023: $3.45Q4 2023: $4.32Q1 2024: $5.88Q2 2024: $6.02Q3 2024: $5.97Q4 2024: $4.36Q1 2025: $2.15Q2 2025: $1.25Q3 2025: $0.83Q4 2025: $0.66Q1 2026: $1.70Q2 2026: $2.89Forward: $1.79
Q3 2023: $3.45Q4 2023: $4.32Q1 2024: $5.88Q2 2024: $6.02Q3 2024: $5.97Q4 2024: $4.36Q1 2025: $2.15Q2 2025: $1.25Q3 2025: $0.83Q4 2025: $0.66Q1 2026: $1.70Q2 2026: $2.89Forward: $1.79
QuarterTTM EPSYoY
Forward$1.79-38%
Q2 2026$2.89+131%
Q1 2026$1.70-21%
Q4 2025$0.66-85%
Q3 2025$0.83-86%
Q2 2025$1.25-79%
Q1 2025$2.15-63%
Q4 2024$4.36+0.9%
Q3 2024$5.97+73%

CMBT's earnings per share have fallen from their peak: $2.89 over the past year, against $6.02 in mid-2024. Its recent earnings include one-off gains.

CMBT Quarterly Revenue

Q3 2023: $271MQ4 2023: $278MQ1 2024: $239MQ2 2024: $251MQ3 2024: $222MQ4 2024: $226MQ1 2025: $235MQ2 2025: $388MQ3 2025: $454MQ4 2025: $589MQ1 2026: $520MQ2 2026: $691M
Q3 2023: $271MQ4 2023: $278MQ1 2024: $239MQ2 2024: $251MQ3 2024: $222MQ4 2024: $226MQ1 2025: $235MQ2 2025: $388MQ3 2025: $454MQ4 2025: $589MQ1 2026: $520MQ2 2026: $691M
QuarterRevenueYoY
Q2 2026$691.4M+78%
Q1 2026$519.6M+121%
Q4 2025$589M+161%
Q3 2025$454.2M+105%
Q2 2025$387.8M+55%
Q1 2025$235M-1.6%
Q4 2024$226M-19%
Q3 2024$221.8M-18%

CMBT's revenue is recovering but still below its 2020 peak: $691M last quarter, up 78% from the same quarter a year ago.

CMBT Free Cash Flow

Q3 2023: $89MQ4 2023: $192MQ1 2024: $86MQ2 2024: −$264MQ3 2024: −$160MQ4 2024: −$310MQ1 2025: −$198MQ2 2025: −$292MQ3 2025: −$134MQ4 2025: $12MQ1 2026: $167MQ2 2026: $250M
Q3 2023: $89MQ4 2023: $192MQ1 2024: $86MQ2 2024: −$264MQ3 2024: −$160MQ4 2024: −$310MQ1 2025: −$198MQ2 2025: −$292MQ3 2025: −$134MQ4 2025: $12MQ1 2026: $167MQ2 2026: $250M
QuarterFree cash flowYoY
Q2 2026$249.9M+$542.3M
Q1 2026$167.4M+$364.9M
Q4 2025$11.7M+$322M
Q3 2025-$133.8M+$26.4M
Q2 2025-$292.4M-$28.1M
Q1 2025-$197.6M-330%
Q4 2024-$310.3M-262%
Q3 2024-$160.2M-280%

CMBT's free cash flow has turned positive again: $295M over the past year, against −$960M the year before.

CMBT Total Shares

Q3 2023: 202MQ4 2023: 202MQ1 2024: 202MQ2 2024: 194MQ3 2024: 194MQ4 2024: 195MQ1 2025: 194MQ2 2025: 194MQ3 2025: 239MQ4 2025: 290MQ1 2026: 290MQ2 2026: 290M
Q3 2023: 202MQ4 2023: 202MQ1 2024: 202MQ2 2024: 194MQ3 2024: 194MQ4 2024: 195MQ1 2025: 194MQ2 2025: 194MQ3 2025: 239MQ4 2025: 290MQ1 2026: 290MQ2 2026: 290M
PeriodChange %Net change
Quarterly0%--
1 year+49%+96M shares
3 years+44%+88.3M shares
5 years+38%+80M shares
Available history+83%+132M shares

CMBT has 290M diluted shares, up 49% from a year ago.

CMBT Net Leverage

Q3 2023: 1.5xQ4 2023: 0.6xQ1 2024: 0.9xQ2 2024: 1.7xQ3 2024: 2.0xQ4 2024: 2.2xQ1 2025: 6.6xQ2 2025: 7.3xQ3 2025: 7.3xQ4 2025: 6.3xQ1 2026: 4.4xQ2 2026: 4.0x
Q3 2023: 1.5xQ4 2023: 0.6xQ1 2024: 0.9xQ2 2024: 1.7xQ3 2024: 2.0xQ4 2024: 2.2xQ1 2025: 6.6xQ2 2025: 7.3xQ3 2025: 7.3xQ4 2025: 6.3xQ1 2026: 4.4xQ2 2026: 4.0x
QuarterNet LeverageStatus
Q2 20264.0xElevated
Q1 20264.4xHigh
Q4 20256.3xHigh
Q3 20257.3xHigh
Q2 20257.3xHigh
Q1 20256.6xHigh
Q4 20242.2xModerate
Q3 20242.0xHealthy

CMBT's net debt is about 4.0 years of its operating earnings (EBITDA), down from 7.3 years a year ago.

CMBT Weekly Momentum

MetricValueStatus
RSI52.6Neutral
Stochastic33.0Neutral

CMBT's weekly RSI is 53 (neutral) and its Stochastic is 33 (neutral).

CMBT PE vs Industrials Sector

MetricCMBTSector medianRelative
PE6.1x24x75% below
PE %455813 pts below

CMBT is trading at 6.1x earnings, a 75% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.

CMBT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$18.54.7% below
20 week MA$17.70.5% below
50 week MA$14.819% above
100 week MA$12.245% above
200 week MA$14.323% above

CMBT has slipped below its 8- and 20-week averages, though it's still 23% above its 200-week average.

CMBT Yearly ROI

YearStart priceEnd priceROI
2020$12.2$8.08-34%
2021$8.08$8.81+9%
2022$8.81$17.2+96%
2023$17.2$17.6+2%
2024$17.6$10.0-43%
2025$10.0$9.70-3.3%
2026 YTD$9.70$17.6+82%

CMBT is up 82% so far in 2026, after finishing lower in three of the previous six years.

Give your agent the market.

Get API key